TC
Therapeutic Areas
Baymatob Operations Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Oli PPH | Postpartum Hemorrhage (PPH) Risk Prediction | Phase 3 |
Leadership Team at Baymatob Operations
DS
Dr Sarah McDonald
Founder & CTO
DO
David O’Reilly
Chair of the Board
SA
Santhi Analytis
Non‑Executive Director